Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T00:17:15.393Z Has data issue: false hasContentIssue false

6 - Insomnias

from SECTION 2 - SLEEP DISORDERS

Published online by Cambridge University Press:  08 August 2009

James K. Wyatt
Affiliation:
Rush University Medical Center
M. Isabel Crisostomo
Affiliation:
Rush University Medical Center
Harold R. Smith
Affiliation:
University of California, Irvine
Cynthia L. Comella
Affiliation:
Rush University Medical Center, Chicago
Birgit Högl
Affiliation:
Inssbruck Medical University
Get access

Summary

Introduction

Insomnia is one of the most common complaints seen in medicine. Incidence and prevalence estimates vary slightly depending on the methodology, but commonly cited figures are that approximately one-third of Americans have symptoms of acute or intermittent insomnia, and that approximately 10% have chronic insomnia. Over the past several decades, there have been great strides in understanding the pathophysiology of insomnia as well as documenting the efficacy of pharmacologic and nonpharmacologic treatments. There are now sufficient data to allow for meta-analyses to be conducted in insomnia, which help compare effect sizes across studies. This chapter provides an overview of the development of insomnia, information required to make a diagnosis of insomnia, the various recognized insomnia diagnoses, and the pharmacologic, cognitive, and behavioral treatments available.

Pathophysiology of the insomnias

As with certain other sleep disorders, there are cases where insomnia is thought to be a primary condition, times when it is thought to have come about entirely secondary to a medical or psychiatric condition, and times when it may be comorbid with other significant illnesses. There are many theories for the development of insomnia itself, including theories relying on cognitive styles, psychiatric vulnerabilities, and physiological sensitivity or over-reactivity. In 1986 Spielman proposed a particularly useful model of the development of chronic insomnia that allows for multiple etiologies – the “3 P model.”

Spielman's model assumes that certain individuals have a predisposition (the first P) to develop insomnia.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×